[1]
Tolba, M.K.A., Khashab, K.A.E. and Said, A.S.A. 2017. THEEFFECT OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETES MELLITUS. International Journal of Pharmacy and Pharmaceutical Sciences. 9, 1 (Jan. 2017), 254–259. DOI:https://doi.org/10.22159/ijpps.2017v9i1.15496.